Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Fallopian Tube Neoplasms 7Ovarian Neoplasms 6Breast Neoplasms 4Multiple Myeloma 3Lymphoma 3Sarcoma, Kaposi 2Neoplasms 2Multi-centric Castleman's Disease 2Leukemia 2Hodgkin Disease 2Triple Negative Breast Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Sarcoma, Synovial 1Sarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Platinum-Refractory Fallopian Tube Carcinoma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Lymphadenopathy 1

Interventions

Zidovudine 9Interferon alpha-2 5Doxorubicin 5Vincristine 4Bleomycin 4pomalidomide 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3sargramostim 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Didanosine 2Biopsy 2Bevacizumab 2tocilizumab 1pembrolizumab 1halofuginone 1entinostat 1cabozantinib 1abemaciclib 1Zalcitabine 1Valganciclovir 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Sarcoma, Kaposi × liposomal doxorubicin × Clear all
NCT02659930 2026-06-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
62 enrolled
Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT00923936 2018-07-24

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
16 enrolled 13 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡